M3V.XETRA MeVis Medical Solutions AG

Healthcare Health Care Technology XETRA Stock Exchange
19.70 EUR
Close of Nov 5, 2026
19.60 25.83
Market cap
EUR 35.9M
P/E
46.9x
P/B
2.04x
ROE
7.0%
Dividend yield
12.72%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Mar 2026.

Is M3V.XETRA undervalued?

Graham number
Price19.70
Graham value9.55
Premium106.3%

M3V.XETRA trades 106.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MeVis Medical Solutions AG fundamental analysis

No fundamental analysis for MeVis Medical Solutions AG yet.

MeVis Medical Solutions AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MeVis Medical Solutions AG

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammogra…

Full company profile